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Effect of acute uremia on various aspects of carbohydrate
metabolism in dogs. Dogs were studied before and five days
after diversion of both ureters into the vena cava. Mean (± SEM)
serumcreatinine concentration (24 dogs) increased from 0.9 0.03
to 15.3±0.05 mg/lOOml (P<0.001). Mean (±5EM) fasting
plasma glucose concentration rose from 82 1.6 to 96 3.7 mgI
100 ml during the same period (P<0.Ol). The effect of uremia
on insulin resistance was studied in nine dogs by measuring
their steady state plasma glucose response to continuous infusion
of epinephrine, propranolol, glucose and insulin. When this
approach is followed insulin secretion and hepatic glucose out-
put are inhibited, similar steady state levels of circulating insulin
are achieved in all dogs and the height of the steady state plasma
glucose response becomes a direct measure of insulin resistance.
In all dogs the steady state plasma glucose concentration was
higher during the uremic study (P<0.002). Finally, steady state
insulin responses to continuous glucose infusions were measured
in fifteen dogs. Steady state plasma glucose concentrations were
higher during the uremic study in all dogs (P< 0.001), but steady
state insulin responses were identical. Thus, acute uremia leads
to glucose intolerance, which is at least partly due to develop-
ment of insulin resistance, and is not associated with an actual
decrease in insulin response.
Effets de l'urémie aiguë sur divers aspects dii métabolisme des
hydrates de carbone chez le chien. Des chiens ont été étudiés
avant et cinq jours aprés derivation des deux uretCres dans Ia
veine cave. La crCatininCmie moyenne (± sEM) de 24 chiens a
augmentC de 0,9 0,03 mg/100 ml a 15,3 0,05 mg/ 100 ml
(P< 0,001). La moyenne de Ia glycémie a jeun (± SEM) a aug-
menté de 82±1,6 mg/l00 ml a 96±3,7 mg/100 ml pendant Ia
mCme période (P<0,01). L'effet de l'urémie sur Ia résistance a
l'insuline a été Ctudié chez neuf chiens par Ia determination de
leur concentration plasmatique de glucose a l'état stationnaire
au cours d'une perfusion continue d'CpinCphrine, de propanolol,
de glucose et d'insuline. Dc cette facon Ia secretion d'insuline
et Ia liberation hépatique de glucose sont inhibés et des états
stationnaires semblables d'insuline circulante sont réalisés. Ainsi
Ic niveau de l'état stationnaire de glucose plasmatique devient
une mesure directe de Ia résistance a l'insuline. Chez tous les
chiens Ic glucose plasmatique a l'état stationnaire a etC plus
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ClevC pendant la période urCmique (P<0,002). Enf in Ia rCponse
stationnaire d'insuline au cours d'une perfusion continue de
glucose a Cté mesurée chez 15 chiens, La glucose plasmatique
a l'Ctat stationnaire était plus ClevC pendant Ia période urémique
chez tous les chiens (P<0,001) mais la rCponse stationnaire
d'insuline était identique. Ainsi l'urCmie aigud conduit a une
diminution de Ia tolerance au glucose, liée en partie a l'appari-
tion d'une résistance a l'insuline et non associée a une diminution
réelle de Ia rCponse insulinique.
Although it has been known for some time that glucose
intolerance can occur in patients with renal failure [1—4],
this phenomenon received relatively little attention until
the last decade. The revival of interest in the effect of
uremia on carbohydrate tolerance is most likely related to
the institution of dialysis as a method of treatment and the
discovery of a specific method for measurement of insulin
concentration. As a result of these scientific advances, con-
siderable attention has been directed toward the problem,
and it is generally assumed that renal failure is associated
with deterioration of carbohydrate tolerance. There is,
however, less agreement as to the cause of the carbohydrate
intolerance, and evidence has been presented implicating
both impaired insulin secretion [5—7] and resistance to the
action of insulin [8—13] as being responsible for the ab-
normality of glucose metabolism. These conclusions have
been primarily reached as a result of studies of plasma
glucose and immunoreactive insulin responses to orally or
intravenously administered glucose loads, and the lack of
consensus primarily relates to three defects which have
been present in most earlier methods of study.
The first problem has been the assumption that the
height of the plasma insulin response provides an accurate
estimate of insulin resistance. Thus, if a patient with uremia
responds to orally administered glucose with increased
plasma glucose and insulin concentrations, it is frequently
concluded that the patient is hyperglycemic even though
he secretes greater than normal amounts of insulin, i.e.,
that "insulin resistance" is the cause of the glucose in-
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tolerance. This may be a valid conclusion in patients with
normal renal function, but realization of the crucial role
of the kidney in insulin removal from plasma (14—171 makes
it impossible to assume that elevated insulin concentrations
in patients with renal failure indicate that uremia causes
insulin resistance. A second problem results from the use
of inadequate methods to measure plasma glucose con-
centrations. Plasma glucose concentrations will be elevated
to false levels if methods which measure total reducing
substances are used in patients with uremia [11, 13]. On
the other hand, elevated uric acid concentrations can inter-
fere with measurement of plasma glucose by the glucose
oxidase-peroxidase method [18], resulting in falsely low
glucose values in uremic patients. Third, there is the prob-
lem of interpreting the meaning of the changing relation-
ship that exists between plasma glucose and insulin con-
centrations during a glucose tolerance test when both
variables are rapidly rising and falling.
In order to avoid all three of these dilemmas, we em-
ployed a somewhat different experimental approach in an
effort to define the cause of glucose intolerance in acute
uremia. In the first place, we produced experimental
uremia in dogs by diverting the ureters into the vena cava.
In this manner uremia is produced without loss of renal
mass, and the removal rate of insulin from the plasma of
dogs made uremic by ureteral diversion is normal [17].
Second, we measured plasma glucose concentration by the
glucose oxidase method. Since dogs can convert uric acid
to allantoin, hyperuricemia does not occur in uremic dogs;
under these conditions glucose oxidase provides a specific
measure of plasma glucose concentration. Third, we esti-
mated the effect of acute renal failure on carbohydrate
tolerance in dogs during steady state conditions in which
plasma glucose and insulin concentrations bear a constant
relationship to each other, and under conditions in which
we could separate the effect of uremia on insulin resistance
from its effect on insulin secretion.
Methods
Experimental protocol. A control evaluation of either
insulin resistance or insulin secretion (to be described in
detail) was carried out in 29 bitches, weighing 18 to 27 kg.
One week later acute uremia was produced in 24 dogs in
the following manner. Dogs were anesthetized with pento-
barbital sodium, and both ureters, with attached mucosa
and muscularis, were removed from the bladder and anas-
tomosed to the inferior vena cava just below the right
ovarian vein. In this manner acute uremia was produced
without loss of renal mass, and under conditions in which
glucose intolerance occurs without any change in the rate
of removal of insulin [17, 19] from the plasma of uremic
dogs. In five dogs sham ureteral diversion was performed,
in which the ureters were removed from the bladder and
then reimplanted. Autopsies were performed after the
studies were completed, and in no instance had visible
hydronephrosis developed. Five days later each dog was
restudied, repeating the initial study in an identical fashion.
Thus, each dog served as his own control. Dogs were fed
a regular kennel diet, making sure that each dog received
100 g of glucose daily for four days before the control and
experimental studies (in the case of uremic animals, this
often had to be accomplished by intravenous infusion).
Fluid intake was held constant in the uremic dogs to
maintain normal serum sodium concentrations, and poly-
styrene sulfonate was administered when serum potassium
concentrations exceeded 6 mEq/liter.
Evaluation of insulin resistance and secretion. 1. Estimates
of insulin resistance. Experiments were performed in
14 awake dogs (nine with bilateral ureteral diversion and
five who underwent sham diversion) after a 24-hour fast.
Insulin resistance was estimated by a method previously
described and validated, in which experimental subjects
receive a constant intravenous infusion of epinephrine,
propranolol, glucose and crystalline insulin [20]. By this
procedure endogenous insulin secretion and hepatic glu-
cose output are inhibited, and similar circulating levels
of exogenous insulin are produced in each animal.
In order to insure that suppression of endogenous insulin
secretion could be accomplished in the uremic state, simul-
taneous measurements of cephalic and portal vein insulin
were performed at the end of 7 of the 9 uremic studies.
The results are shown in Fig. 1. The fact that portal vein
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Fig. I. Comparison of portal and cephalic vein insulin concentra-
tions during continuous infusion of epinephrine, propranolol, glucose
and exogenous insulin. Blood for these measurements was ob-
tained at the end of the studies of insulin resistance, following
abdominal laparotomy.
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Table 1. Mean (± 5EM) fasting concentrations of creatinine, sodium, potassium, glucose, and insulin
before and after the induction of uremia (N= 24 dogs)
Creatinine
mg/100ml
Sodium
mEqiliter
Control Uremia
Potassium
mEq/liter
Glucose
mg/100 ml
Control Uremia
Insulin
pU/mi
Control UremiaControl Uremia Control Uremia
0.9±0.03 15.3 ±0.05 144±1.6 4.4±0.07 5.4±0.2 82± 1.6 96± 3.7 19±0.09 19± 1.2
P<o.oola P=NS P <o.ola r <o.ola P=NS
a Student t-test.
and cephalic vein insulin concentrations are essentially
identical indicates that suppression of endogenous insulin
secretion is also produced in uremia. Under these condi-
tions, the height of the steady state plasma glucose con-
centration which results from the continuous glucose in-
fusion is a direct measure of the ability of exogenous insulin
to promote glucose uptake, e.g., it provides a direct measure
of the dogs' resistance to the infused insulin. Each dog was
given a loading dose of propranolol (0.07 mg/kg) and then
received an infusion of glucose (8mg/kg of body weight! mm),
epinephrine (0.08 pg/kg/mm), propranolol (0.0017 mg/kg/
mm), and one of two doses of insulin (10 or 25 mU/mm)
for 130 minutes into the cephalic vein. Blood was drawn
from a catheter placed in the saphenous vein before and
every 10 minutes (starting at 90 minutes) after the infusion
was begun. The mean steady state plasma glucose and
insulin responses were determined from five samples drawn
90, 100, 110, 120 and 130 minutes after the beginning of
the infusion.
2. Estimates of insulin secretion. Experiments were per-
formed in an identical fashion on 15 dogs except that the
continuous intravenous infusion contained only glucose.
Five dogs received 7 mg/kg/mm; six dogs, 11 mg/kg/mm;
and four dogs, 14 mg/kg/mm. The height of the steady
state insulin response to the continuous glucose infusion
provides an estimate of the insulin secretory response, which
can be considered in absolute terms, as well as in relation-
ship to the steady state plasma glucose concentration that
is achieved.
Analytical procedures. Blood was drawn into tubes con-
taining EDTA. Plasma was separated immediately, quickly
frozen in acetone-dry ice, and stored at —20°C. Immuno-
reactive insulin concentrations were measured at each
time-point in triplicate by the method of Hales and
Randle [21] and plasma glucose concentration by a modi-
fication of a glucose oxidase method adapated for the auto-
analyzer (Technicon) [22]. The plasma immunoreactive
insulin and glucose concentrations from both control and
experimental studies were measured on the same day to
minimize technical variation.
Results
Fasting glucose and insulin concentrations. The mean
fasting creatinine, sodium, potassium, glucose and insulin
concentrations for all 24 dogs appear in Table 1. It is
apparent that bilateral ureteral diversion results in the
development of severe uremia, with a mean creatinine
concentration of 15.3 mg/100 ml. In spite of this intense
degree of uremia, mean fasting plasma glucose concentra-
tions only rose from 82 to 96 mg/100 ml. This increase was
statistically significant (P<0.01), but it is obvious that
the deterioration of glucose tolerance was not as dramatic
as the degree of uremia. It can also be seen from Table 1
that acute uremia had no effect on mean fasting plasma
insulin concentrations.
Effect of acute uremia on "insulin resistance." The ability
of continuous infusions of exogenous insulin to promote
glucose uptake before and after the production of acute
uremia is seen in Table 2. Since mean fasting glucose con-
centrations are given in Table 1, only the steady state
glucose increments above fasting concentrations are in-
cluded in Table 2 for purposes of clarity. In the first place,
it is obvious that the steady state insulin concentrations
achieved as the result of the exogenous insulin infusions
were similar in the control and uremic studies, and this
was true with both "low" and "high" insulin infusion
rates. It is also obvious that the increments in steady state
plasma glucose concentrations above fasting were greater
after the induction of acute uremia in all nine dogs, and
Table 2. Effect of acute uremia on insulin resistance in nine dogs
Increment in Steady state
glucose levela insulin levels
Treatment mg/100 ml pU/mI
Control Uremia Control Uremia
"Low" insulin 60 203 25 22
infusion 123 187 21 22
lOmU/min 45 59
10 59
20 20
18 17
Mean± SEM 60±24 127± 39 21±1 20±1
"High" insulin 7 74 57 52
infusion 12 73 55 75
2SmU/min 13 25
1 3
2 16
52 48
44 48
46 42
Mean±sEM 7±2 38±15 51±3 53±6
a Increment in glucose level = steady state level — fasting level.
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this was the case with both "low" and "high" insulin
infusions. The probability of this happening by chance,
using the Sign test [23], is 1 ÷2, or P<0.002. As might be
anticipated, the increments in plasma glucose concentra-
tions were less in both control and uremic studies when the
exogenous infusion rate was the highest. Finally, the results
listed in Table 3 indicate that sham ureteral diversion did
not lead to hyperglycemia.
Effect of acute uremia on insulin response. The changes
in steady state glucose and insulin concentrations that
occur in acute uremia following the administration of
Table 3. Effect of sham ureteral diversion on insulin resistance
in five dogs
Increment in Steady state
glucose levela insulin levels
Treatment mg/100 ml p U/mi
Control Sham Control Sham
"High" insulin 7 4 50 40
infusion 11 8 43 45
2SmU/min 1 12
14 4
2 5
66 56
47 57
55 61
Mean±sEM 7±3 7±2 52±4 52±4
a Increment in glucose level = steady state level — fasting level.
Table 4. The effect of acute uremia on the steady state
plasma concentrations of glucose and insulin to infusions
of glucose alone
Increment a Increment a
in glucose in insulin
Glucose concentration concentration
infusion mg/100 ml pU/mi
Control Uremia Control Uremia
7 mg/kg/mm 85 126
49 53
21 131
25 36
61 87
10 16
3 20
17 9
14 50
4 7
Mean±sEM 48± 12 87±43 10±6 20± 17
11 mg/kg/mm 45 116
86 96
74 103
99 112
71 96
19 39
28 41
13 8
32 19
29 40
8 14
12 10
Mean SEM 66 12 94 11 20±4 22 6
14mg/kg/mm 50 211
84 125
52 65
108 156
38 42
85 70
39 53
38 37
Mean 74± 14 139± 30 50± 12 51±7
a Increment = steady state level — fasting level.
glucose at three different rates of infusion are shown in
Table 4. As before, fasting concentrations have been elimi-
nated for clarity, and only the increments in steady state
concentrations are presented. Infusion of larger amounts
of glucose resulted in greater increments in steady state
concentrations of glucose and insulin in both control and
uremic studies. However, at all three glucose infusion rates,
the increments in steady state plasma glucose concentra-
tions were always greater following the induction of acute
uremia. The probability that this could have occurred by
chance is equal to 1÷215 [23], or P<0.001. In contrast,
there was no difference between the increments in steady
state plasma insulin concentrations in studies conducted
before and after acute uremia had developed.
Discussion
In these studies we utilized an experimental model of
acute uremia which maintains renal mass, and in this
manner we eliminated the variable effect of differences in
renal removal of insulin that occurs when uremia is second-
ary to loss of renal parenchyma. Furthermore, by restrict-
ing our measurements to steady state conditions, and by
measuring plasma glucose with a method which is not
subject to the methodological artifacts which occur in
uremia, we avoided the three major defects of previous
studies of the effect of uremia on glucose and insulin
metabolism. Under these conditions, the results of these
studies clearly indicate that acute uremia results in a
deterioration of glucose tolerance. Unfortunately, the re-
sults are somewhat less unequivocal when it comes to the
mechanism by which acute uremia produces glucose in-
tolerance.
The deleterious effect of acute uremia on glucose toler-
ance could be seen in the fasting state, after the combined
infusion of exogenous insulin and glucose and after the
infusion of glucose alone. However, although all three
approaches gave qualitatively similar results, the effect
of uremia on fasting plasma glucose concentrations was
quantitatively less than that seen in response to the challenge
of the glucose infusions. Thus, it appears that the develop-
ment of acute uremia (mean serum creatinine value =
15.3 mg/l0O ml) in previously normal dogs has a clear, but
relatively modest effect on carbohydrate tolerance, affect-
ing primarily the ability to respond to a glucose challenge.
At least partly responsible for the decreased ability of
uremic animals to respond to a glucose challenge is the
development of insulin resistance. By suppressing endog-
enous insulin secretion, and infusing equal amounts of
glucose and insulin into each dog, we have a simple experi-
mental model in which the height of the steady state plasma
glucose concentration before and after uremia provides a
direct comparison of the effect of uremia on insulin-
mediated glucose uptake. Thus, the mean steady state
plasma glucose increment in response to a constant intra-
venous infusion of crystalline insulin (10 mU/mm) and
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8 mg of glucose/kg of body weight/mm was 60 mg/100 ml
before and 127 mg/100 ml after bilateral ureteral diversion.
Similarly, the mean glucose increment during the same
glucose load and the higher insulin infusion rate (25mU)
was 7 mg/100 ml before and 38 mg/100 ml after the induc-
tion of uremia. This effect of uremia was significant at the
P< 0.002 level. Since the mean steady state plasma insulin
concentrations were the same before and after uremia, it
seems reasonable to attribute the larger increments in
plasma glucose concentration to an increase in insulin
resistance, secondary to the development of acute uremia.
In contrast, evidence for an abnormality of pancreatic
insulin secretion in uremia is less clear. With the induction
of acute uremia, dogs showed a decreased ability to dispose
of a continuously infused glucose load. This was seen at
all three glucose infusion rates, and reinforces the conclu-
sion that acute uremia results in a decreased ability to
transport glucose. Plasma insulin concentrations increased
as the glucose loads were increased, but this was true both
before and after acute uremia had developed, and there
was no difference in the insulin response before and after
uremia. Thus, the impaired glucose response seen in uremia
cannot be due to an absolute decrease in the insulin
response. However, one might argue that uremia results in
higher steady state plasma glucose concentrations and that
the uremic dog should respond with an appropriately
increased insulin response. In this sense, the fact that the
insulin concentrations were identical before and after
uremia supports the notion that uremia results in a de-
crease in the ability of the pancreas to secrete insulin.
Obviously, the conclusion as to the role of impaired insulin
secretion in the genesis of the glucose intolerance of uremia
depends upon the relationship between plasma glucose
concentration and insulin response. If one assumes that
the plasma insulin response is a direct linear function of
the plasma glucose response, the plasma insulin concentra-
tions seen in uremia can be interpreted as being inappro-
priate and indicative of an abnormal pancreatic response.
On the other hand, there is no a priori reason to assume
that the insulin response is a direct linear function of plasma
glucose concentration, and there is considerable evidence
[24, 25] which suggests that the insulin response is more a
function of administered glucose load than of plasma
glucose concentration. In this context, the identity of the
plasma insulin response to the continuous glucose infusions
before and after uremia leads to the conclusion that acute
uremia had no effect on the endogenous insulin response
to a glucose challenge and that the deleterious effect of
uremia is entirely due to the development of insulin
resistance. Obviously, the ultimate decision as to the role
of endogenous insulin release in the glucose intolerance of
acute uremia will depend upon increased understanding of
the factors controlling insulin release.
Finally, it must be emphasized that caution should be
used in relating these results to the question of carbohydrate
tolerance in patients with chronic renal failure. Obviously,
the effects of acute uremia on glucose and insulin metabo-
lism in dogs need not be identical to the effects of chronic
uremia in humans. Nonetheless, these studies do point out
that severe and acute uremia does modify glucose homeo-
stasis in dogs, that the effect is relatively modest and
primarily affects the ability of dogs to respond to a glucose
challenge, that acute uremia is associated with an increase
in insulin resistance and that the absolute insulin response
to glucose is unchanged.
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